| Nuclear localization of dengue virus (DENV) 1–4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin MYF Tay, JE Fraser, WKK Chan, NJ Moreland, AP Rathore, C Wang, ... Antiviral research 99 (3), 301-306, 2013 | 359 | 2013 |
| Novel Wolbachia-transinfected Aedes aegypti mosquitoes possess diverse fitness and vector competence phenotypes JE Fraser, JT De Bruyne, I Iturbe-Ormaetxe, J Stepnell, RL Burns, ... PLoS pathogens 13 (12), e1006751, 2017 | 125 | 2017 |
| A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection JE Fraser, S Watanabe, C Wang, WKK Chan, B Maher, A Lopez-Denman, ... The Journal of infectious diseases 210 (11), 1780-1791, 2014 | 99 | 2014 |
| Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry J Fraser, I Boo, P Poumbourios, HE Drummer Journal of Biological Chemistry 286 (37), 31984-31992, 2011 | 53 | 2011 |
| Novel phenotype of Wolbachia strain wPip in Aedes aegypti challenges assumptions on mechanisms of Wolbachia-mediated dengue virus inhibition JE Fraser, TB O’Donnell, JM Duyvestyn, SL O’Neill, CP Simmons, ... PLoS Pathogens 16 (7), e1008410, 2020 | 43 | 2020 |
| Novel flavivirus antiviral that targets the host nuclear transport importin α/β1 heterodimer SNY Yang, SC Atkinson, JE Fraser, C Wang, B Maher, N Roman, ... Cells 8 (3), 281, 2019 | 38 | 2019 |
| Using Wolbachia to Eliminate Dengue: Will the Virus Fight Back? KM Edenborough, HA Flores, CP Simmons, JE Fraser Journal of virology 95 (13), 10.1128/jvi. 02203-20, 2021 | 36 | 2021 |
| Wolbachia’s Deleterious Impact on Aedes aegypti Egg Development: The Potential Role of Nutritional Parasitism MJ Allman, JE Fraser, SA Ritchie, DA Joubert, CP Simmons, HA Flores Insects 11 (11), 735, 2020 | 35 | 2020 |
| Investigating dengue virus nonstructural protein 5 (NS5) nuclear import JE Fraser, SM Rawlinson, C Wang, DA Jans, KM Wagstaff Dengue: methods and protocols, 301-328, 2014 | 34 | 2014 |
| Novel dengue virus inhibitor 4-HPR activates ATF4 independent of protein kinase R–like Endoplasmic Reticulum Kinase and elevates levels of eIF2α phosphorylation in virus … JE Fraser, C Wang, KWK Chan, SG Vasudevan, DA Jans Antiviral Research 130, 1-6, 2016 | 30 | 2016 |
| Dynamic nucleolar targeting of dengue virus polymerase NS5 in response to extracellular pH JE Fraser, SM Rawlinson, SM Heaton, DA Jans Journal of Virology 90 (12), 5797-5807, 2016 | 23 | 2016 |
| High throughput screening targeting the dengue NS3-NS5 interface identifies antivirals against dengue, Zika and West Nile viruses SNY Yang, B Maher, C Wang, KM Wagstaff, JE Fraser, DA Jans Cells 11 (4), 730, 2022 | 8 | 2022 |
| Transient Introgression of Wolbachia into Aedes aegypti Populations Does Not Elicit an Antibody Response to Wolbachia Surface Protein in Community Members E Lee, T Hien Nguyen, T Yen Nguyen, S Nam Vu, N Duong Tran, ... Pathogens 11 (5), 535, 2022 | 5 | 2022 |
| Method of viral inhibition JE Fraser, DA Jans, KM Wagstaff US Patent 11,007,160, 2021 | 3 | 2021 |
| Statement in Support of:“Virology under the Microscope—a Call for Rational Discourse” P Speck, J Mackenzie, RA Bull, B Slobedman, H Drummer, J Fraser, ... Mbio 14 (3), e00815-23, 2023 | 1 | 2023 |
| Enhancing the scalability of Wolbachia-based vector-borne disease management: time and temperature limits for storage and transport of Wolbachia-infected Aedes aegypti eggs for … MJ Allman, YH Lin, DA Joubert, J Addley-Cook, MC Mejía-Torres, ... Parasites & Vectors 16 (1), 108, 2023 | 1 | 2023 |
| Method of viral inhibition JE FRASER, DA JANS, KM WAGSTAFF AU Patent App. 2,019,213,440 A, 2019 | 1 | 2019 |
| Method of viral inhibition JE Fraser, DA Jans, KM Wagstaff US Patent App. 18/355,802, 2024 | | 2024 |
| AntiviralWolbachiastrains associate withAedes aegyptiendoplasmic reticulum membranes and disturb host cell lipid distribution to restrict dengue virus replication. R Kriiger-Loterio, E Monson, R Templin, JT Bruyne, HA Flores, ... | | 2023 |
| Method of viral inhibition JE Fraser, DA Jans, KM Wagstaff US Patent 11,752,116, 2023 | | 2023 |
